Epilepsy Drug Retigabine May Reduce Brain Damage in Ischemic Stroke

Mouse model
Mouse model
The mice treated with retigabine showed no signs of stroke.

Stroke is a leading cause of long-term disability in the US, affecting more than 795,000 Americans every year. But according to a new study, a drug already approved to treat epilepsy may also be effective in reducing brain damage for individuals who have ischemic stroke – the most common form of stroke.

The research team, led by Dr. Sonya Bierbower of the School of Medicine at the University of Texas (UT) Health Science Center at San Antonio, publishes its findings in The Journal of Neuroscience.

READ FULL ARTICLE Curated publisher From Medical News Today